Clinical Trial Update: Combination HTNV and PUUV DNA Vaccine [Phase 1]

View source ↗

Summary

A Phase 1 trial updating completion and results posting for a combination Hantaan virus and Puumala virus DNA vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Fever with Renal Syndrome
• Nephropathia Epidemica

Drugs mentioned

• HTNV-PUUV DNA vaccine (DNA vaccine encoding antigens from Hantaan virus and Puumala virus)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Hantaan Virus Disease, Puumala Virus | Phase 1 | Status: COMPLETED | Results posted: 2025-06-26